MA50151B1 - PROCESS FOR THE PREPARATION OF PIRLINDOLE ENANTIOMERS AND THEIR SALTS - Google Patents
PROCESS FOR THE PREPARATION OF PIRLINDOLE ENANTIOMERS AND THEIR SALTSInfo
- Publication number
- MA50151B1 MA50151B1 MA50151A MA50151A MA50151B1 MA 50151 B1 MA50151 B1 MA 50151B1 MA 50151 A MA50151 A MA 50151A MA 50151 A MA50151 A MA 50151A MA 50151 B1 MA50151 B1 MA 50151B1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- salts
- pirlindole enantiomers
- pirlindole
- enantiomers
- Prior art date
Links
- IWVRVEIKCBFZNF-UHFFFAOYSA-N LSM-1636 Chemical class C1CNC2CCCC3=C2N1C1=CC=C(C)C=C13 IWVRVEIKCBFZNF-UHFFFAOYSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 229950002220 pirlindole Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La présente invention concerne un procédé amélioré pour la préparation d'énantiomères de pirlindole, ou d'un sel pharmaceutiquement acceptable de ceux-ci. (ii) (iii)The present invention relates to an improved process for the preparation of enantiomers of pirlindole, or a pharmaceutically acceptable salt thereof. (ii) (iii)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT2017110038 | 2017-04-21 | ||
| EP17167852.7A EP3392251A1 (en) | 2017-04-21 | 2017-04-24 | Process for the preparation of pirlindole enantiomers and its salts |
| PCT/IB2018/052756 WO2018193415A1 (en) | 2017-04-21 | 2018-04-20 | Process for the preparation of pirlindole enantiomers and its salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA50151A MA50151A (en) | 2021-04-28 |
| MA50151B1 true MA50151B1 (en) | 2021-11-30 |
Family
ID=77631679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA50151A MA50151B1 (en) | 2017-04-21 | 2018-04-20 | PROCESS FOR THE PREPARATION OF PIRLINDOLE ENANTIOMERS AND THEIR SALTS |
Country Status (8)
| Country | Link |
|---|---|
| DK (1) | DK3612535T3 (en) |
| ES (1) | ES2900563T3 (en) |
| HR (1) | HRP20211792T1 (en) |
| HU (1) | HUE056997T2 (en) |
| LT (1) | LT3612535T (en) |
| MA (1) | MA50151B1 (en) |
| RS (1) | RS62667B1 (en) |
| SI (1) | SI3612535T1 (en) |
-
2018
- 2018-04-20 SI SI201830486T patent/SI3612535T1/en unknown
- 2018-04-20 DK DK18746988.7T patent/DK3612535T3/en active
- 2018-04-20 RS RS20211379A patent/RS62667B1/en unknown
- 2018-04-20 ES ES18746988T patent/ES2900563T3/en active Active
- 2018-04-20 MA MA50151A patent/MA50151B1/en unknown
- 2018-04-20 HU HUE18746988A patent/HUE056997T2/en unknown
- 2018-04-20 LT LTEPPCT/IB2018/052756T patent/LT3612535T/en unknown
- 2018-04-20 HR HRP20211792TT patent/HRP20211792T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE056997T2 (en) | 2022-04-28 |
| MA50151A (en) | 2021-04-28 |
| RS62667B1 (en) | 2021-12-31 |
| DK3612535T3 (en) | 2021-11-22 |
| SI3612535T1 (en) | 2022-01-31 |
| LT3612535T (en) | 2021-12-27 |
| HRP20211792T1 (en) | 2022-03-04 |
| ES2900563T3 (en) | 2022-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA41607B1 (en) | Salts of a pi3k inhibitor and methods of preparing these salts | |
| MA43169B1 (en) | Heterocyclic compounds as pi3k-gamma inhibitors | |
| MY199730A (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| EA202193015A1 (en) | CDK INHIBITORS | |
| MA42339A1 (en) | Farnesoid Receptor Modulators x | |
| EP3778605A3 (en) | Lrrk2 inhibitors and methods of making and using the same | |
| WO2015132799A3 (en) | Heterocyclic compounds | |
| MA46337A (en) | PYRIDINE COMPOUND | |
| EA201792478A1 (en) | CONNECTIONS-INHIBITORS OF TRANSMISSION SIGNALS NOTCH PATHWAYS | |
| PH12020550905A1 (en) | Process for preparing antihelmintic 4-amino-quinoline-3-carboxamide derivatives | |
| MA48798B1 (en) | OZANIMOD PRODUCTION PROCESS | |
| NZ746906A (en) | Oxaborole esters and uses thereof | |
| EP4410773A3 (en) | Process for the synthesis of (s) 3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid | |
| MA53427B1 (en) | ARGINASE INHIBITORS AND METHODS OF USE THEREOF | |
| NZ727715A (en) | Novel heterocyclic compounds having prs enzyme inhibitory effect | |
| MA58104B1 (en) | Process and intermediate for the preparation of oxetane-2-ylmethanamine | |
| MA50151B1 (en) | PROCESS FOR THE PREPARATION OF PIRLINDOLE ENANTIOMERS AND THEIR SALTS | |
| MA39449A1 (en) | Process for obtaining enantiomers of optically active pirlindole and salts thereof | |
| EP4021920A4 (en) | IMPROVED PROCESS FOR THE PREPARATION OF ETELCALKETIDE HYDROCHLORIDE | |
| TN2017000448A1 (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease | |
| PH12019550212B1 (en) | Process for the preparation of pirlindole enantiomers and its salts | |
| WO2020232330A8 (en) | Inhibiting agents for bruton's tyrosine kinase | |
| MA50899B1 (en) | Compounds useful for cdk7 inhibition | |
| EP3797104A4 (en) | NEW PROCESSES FOR THE PREPARATION OF A DIAMINOPYRIMIDINE DERIVATIVE OR AN ACID ADDITIONAL SALT THEREOF | |
| MA50149B1 (en) | Process for the preparation of the piperazine ring for the synthesis of pyrazinocarbazole |